These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 8159037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Indobufen: an updated review of its use in the management of atherothrombosis.
    Bhana N, McClellan KJ.
    Drugs Aging; 2001; 18(5):369-88. PubMed ID: 11392445
    [Abstract] [Full Text] [Related]

  • 4. [The effect of indobufen on aortocoronary bypass patency after 1 week and after 1 year].
    Rohn V, Pirk J, Mach T.
    Cor Vasa; 1993; 35(4):162-4. PubMed ID: 8403942
    [Abstract] [Full Text] [Related]

  • 5. [A randomized controlled trial of indobufen versus aspirin in the prevention of bridging restenosis after coronary artery bypass grafting].
    Bai C, Li JX, Yu Y, Liu R, Gao MX, Zhang F, Li HY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May 24; 50(5):466-470. PubMed ID: 35589595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y.
    Circulation; 1989 Nov 24; 80(5):1190-7. PubMed ID: 2680158
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA).
    Cataldo G, Braga M, Pirotta N, Lavezzari M, Rovelli F, Marubini E.
    Circulation; 1993 Nov 24; 88(5 Pt 2):II93-8. PubMed ID: 8222202
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veterans Administration Cooperative Study.
    Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y.
    Circulation; 1988 Jun 24; 77(6):1324-32. PubMed ID: 3286040
    [Abstract] [Full Text] [Related]

  • 12. Aspirin plus clopidogrel therapy increases early venous graft patency after coronary artery bypass surgery a single-center, randomized, controlled trial.
    Gao G, Zheng Z, Pi Y, Lu B, Lu J, Hu S.
    J Am Coll Cardiol; 2010 Nov 09; 56(20):1639-43. PubMed ID: 21050973
    [Abstract] [Full Text] [Related]

  • 13. Antiplatelet drugs in femoropopliteal vein bypasses: a multicenter trial.
    McCollum C, Alexander C, Kenchington G, Franks PJ, Greenhalgh R.
    J Vasc Surg; 1991 Jan 09; 13(1):150-61; discussion 161-2. PubMed ID: 1987387
    [Abstract] [Full Text] [Related]

  • 14. Acetylsalicylic acid and dipyridamole improve the early patency of aorta-coronary bypass grafts. A double-blind, placebo-controlled, randomized trial.
    Rajah SM, Salter MC, Donaldson DR, Subba Rao R, Boyle RM, Partridge JB, Watson DA.
    J Thorac Cardiovasc Surg; 1985 Sep 09; 90(3):373-7. PubMed ID: 3897722
    [Abstract] [Full Text] [Related]

  • 15. The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
    Sharma GV, Khuri SF, Josa M, Folland ED, Parisi AF.
    Circulation; 1983 Sep 09; 68(3 Pt 2):II218-21. PubMed ID: 6347428
    [Abstract] [Full Text] [Related]

  • 16. [Comparative study of anticoagulant management after coronary artery bypass surgery--warfarin versus dipyridamole].
    Yamaguchi A, Kitamura N, Miki T, Tatebayashi T, Kawashima M, Otaki M, Tamura H.
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Apr 09; 40(4):485-9. PubMed ID: 1613273
    [Abstract] [Full Text] [Related]

  • 17. Prevention of one-year vein-graft occlusion after aortocoronary-bypass surgery: a comparison of low-dose aspirin, low-dose aspirin plus dipyridamole, and oral anticoagulants. The CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands.
    van der Meer J, Hillege HL, Kootstra GJ, Ascoop CA, Mulder BJ, Pfisterer M, van Gilst WH, Lie KI.
    Lancet; 1993 Jul 31; 342(8866):257-64. PubMed ID: 8101300
    [Abstract] [Full Text] [Related]

  • 18. Trial of low-dose aspirin plus dipyridamole versus anticoagulants for prevention of aortocoronary vein graft occlusion.
    Pfisterer M, Burkart F, Jockers G, Meyer B, Regenass S, Burckhardt D, Schmitt HE, Müller-Brand J, Skarvan K, Stulz P.
    Lancet; 1989 Jul 01; 2(8653):1-7. PubMed ID: 2567792
    [Abstract] [Full Text] [Related]

  • 19. [Chronic treatment of vascular diseases with indobufen].
    Belcaro G, Errichi BM, Laurora G, Marinucci R, Cesarone MR, De Cenzo A.
    Minerva Cardioangiol; 1989 May 01; 37(5):241-50. PubMed ID: 2779803
    [Abstract] [Full Text] [Related]

  • 20. Effect of various antithrombotic regimens (aspirin, aspirin plus dipyridamole, anticoagulants) on the functional status of patients and grafts one year after coronary artery bypass grafting.
    Mulder BJ, van der Doef RM, van der Wall EE, Tijssen JG, Piek JJ, van der Meer J, Dunning AJ.
    Eur Heart J; 1994 Aug 01; 15(8):1129-34. PubMed ID: 7988607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.